tbuckley/cabot-search huggingface dataset:
Vivovec™ Surface-Engineered Lentiviral Particles Mediate In Vivo CAR T Generation with Potent and Highly Durable Activity in Non-Human Primates
Authors: Maura H. Parker, Kristen L. Mittelsteadt, Justin T. Ulrich-Lewis, Weiliang Tang, Mollie M. McDonnell, Richard Manivanh, Alissa H. Brandes, Nolan Ericson, Angela Soo Min Koo, Greyson Hamilton, Yong Ha Youn, Chang-Chih Wu, Seungjin Shin, Rebecca J Gottschalk, Kelsey L Lynch, Eric Cavanaugh, Hans-Peter Kiem, Andrew M. Scharenberg, Ryan P. Larson, Laurie O. Beitz, Byoung Y. Ryu
Journal: Blood (2024)
Targeting the Myelodysplasia (MDS) Inflammasome with the Oral Wnt/β-Catenin Pathway Inhibitor, ES-3000 in Combination with Oral Decitabine/Cedazuridine (ASTX727) an Australasian Leukaemia and Lymphoma Group Trial (ALLG MDS05/D1)
Authors: Anoop K Enjeti, Suthanthirakannan Ramamoorthy, Devendra Hiwase, Asma Ashraf, Belinda E Butcher, Sushma Kollipara, Carolyn S. Grove, Andrew H Wei, Jake Shortt
Journal: Blood (2024)
The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Authors: Joud El Dick, Jackson Hoesley, Rance C. Siniard, Laura J. Taylor, Cari E. Reed, Marisa B. Marques, Jori E. May
Journal: Blood (2024)
The Mutated of <i>KRAS</i>gene Determine the Fate of KMT2A-Rearranged AML Patients
Authors: Yibo Wu, Xiaolin Yuan, Xiaoyu Lai, Lizhen Liu, Jimin Shi, Weiyan Zheng, Jian Yu, Yanmin Zhao, Jie Sun, Xiujin Ye, Zhen Cai, He Huang, Shanshan Pei, Yi Luo
Journal: Blood (2024)
Daratumumab Plus Lenalidomide (D-R) Versus Lenalidomide (R) Alone As Maintenance Therapy in Newly Diagnosed Multiple Myeloma (NDMM) after Transplant: Analysis of the Phase 3 Auriga Study Among Clinically Relevant Subgroups
Authors: Laahn Foster, Larry D Anderson, Alfred Chung, Chakra Chaulagain, Erin M. Pettijohn, Andrew J. Cowan, Caitlin Costello, Sarah M. Larson, Douglas W. Sborov, Kenneth H. Shain, Rebecca Silbermann, Peter M. Voorhees, Maria Krevvata, Huiling Pei, Sharmila Patel, Vipin Khare, Annelore Cortoos, Robin Carson, Thomas S. Lin, Ashraf Z. Badros
Journal: Blood (2024)
Innovative Model for Creation and Use of Co-Developed Pain Management Plans for Patients with Sickle Cell Disease
Authors: Alexis Thompson, Jasmine Umana, Julia B Sabrick, Therese McKnight, Leslie D Williams, Krupal Rana, William Baar, Lauren Coogle, Osvaldo Mecado, Char M Witmer, Angela M. Ellison, Cynthia F Norris
Journal: Blood (2024)
Final Analysis of Phase 2a Study of Adding Itacitinib to Tacrolimus/Sirolimus Gvhd Prophylaxis after Fludarabine/Melphalan-Based Conditioning Hematopoietic Cell Transplantation for Acute Leukemias, Myelodysplastic Syndrome (MDS), or Myelofibrosis (MF)
Authors: Haris Ali, Dongyun Yang, NI-Chun Tsai, Sally Mokhtari, Tim W Synold, Idoroenyi Amanam, Andrew Artz, Peter T. Curtin, Karamjeet S Sandhu, Anthony S. Stein, Shukaib Arslan, Salman Otoukesh, Firoozeh Sahebi, Joshua Mansour, Paul B. Koller, Amandeep Salhotra, Ibrahim Aldoss, Vinod Pullarkat, Brian J. Ball, Stephen J. Forman, Guido Marcucci, MHD Monzr M. Al Malki, Ryotaro Nakamura
Journal: Blood (2024)
Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 Enhances Anti-Tumor Activity and Obviates the Need for Lymphodepletion in Non-Human Primates
Authors: Sara Sleiman, Tyler Hansen, Nathan D Mathewson, Feng Shen, Miroslaw Kozlowski, Olga Shestova, Maksim Shestov, Danuta Jarocha, Vanessa Gonzalez, Joseph A. Fraietta, Hannah Thomas, Jack Swain, Raimon Duran-Struuck, Kelly D. Moynihan, Paul Bessette, Chris Kimberlin, Meghana Sukthankar, Terrence Park, Andy Yeung, Ivana Djuretic, Saar Gill
Journal: Blood (2024)
Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN)
Authors: Chi-Joan How, Pavlina Chrysafi, Amica Ko, Rebecca Zon, Atefeh Ghorbanzadeh, Dahniel L Sastow, Maria Georgen, Abi Prabhu, Vrushali Pachpande, Sai Sudha Valisekka, Mukul Agarwal, Amiya Ranjan Nayak, May Anne Cheong, Alessandra Iurlo, Daniele Cattaneo, Thita Chiasakul, Rishi Dhawan, Kristen M. Sanfilippo, Gabriela S. Hobbs, Damon E. Houghton, Joan Beckman, Lisa Baumann Kreuziger, Douglas Tremblay, Rushad Patell, Mandy N. Lauw
Journal: Blood (2024)
Crebbp Inhibition Potentiates JAK2 Inhibition in Post-MPN Acute Myeloid Leukemia
Authors: Kalay Bertulfo, Hannah Miller, Ryan Najac, Juan Carlos Castelan, Cindy Ma, Koen Debackere, Wenbin Xiao, Raajit Rampal, Ross L Levine, Chao Lu, Adolfo A. Ferrando, Teresa Palomero
Journal: Blood (2024)
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Authors: Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, Hideki Nakasone, Francis A. Ayuk, Hannah Choe, Noriko Doki, Tetsuya Eto, Aaron Etra, Elizabeth O. Hexner, Nobuhiro Hiramoto, William J. Hogan, Ernst Holler, Keisuke Kataoka, Masatsugu Tanaka, Takashi Tanaka, Naoyuki Uchida, Ingrid Vasova, Fumihiko Ishimaru, Takahiro Fukuda, Yi-Bin Chen, Junya Kanda, Ryotaro Nakamura, Yoshiko Atsuta, James L.M. Ferrara, Yoshinobu Kanda, John Levine, Takanori Teshima
Journal: Blood (2024)
Prospective Cohort Study of Non-COVID Infection in Patients with AML/MDS Undergoing Treatment: Implications for Practice
Authors: Justin CT Loke, Charlotte Gaskell, Emily Yafai, Sonia Fox, Catherine Thomas, Louise Hopkins, Rebecca Boucher, Rebecca Collings, Steve Knapper, Anjum Khan, Jane Nunnick, Katie Randall, Jenny O'Nions, Tom Rider, Arpad Toth, Mary Frances McMullin, Sally Moore, Victoria Drew, Farooq Ahmad Wandroo, Pratap Neelakantan, Pramila Krishnamurthy, Charles Craddock, Sylvia Rofael, Vinit Upsani, David M Lowe, Simon J Stanworth
Journal: Blood (2024)
Machine Learning-Based Predictive Modeling Maximizes the Efficacy of mTOR/TP53 Co-Targeting Therapy Against Acute Myeloid Leukemia
Authors: Jingmei Li, Emi Sugimoto, Keita Yamamoto, Yutong Dai, Sung-Joon Park, Kenta Nakai, Toshio Kitamura, Susumu Goyama
Journal: Blood (2024)
Feasibility, Safety and Efficacy of Oral Maintenance Therapy with Venetoclax Plus Decitabine/Cedazuridine after Venetoclax Plus FluBu2 for High Risk MDS/AML Undergoing RIC Allo-HCT
Authors: Jacqueline S. Garcia, Haesook T. Kim, Jennifer Brock, H. Moses Murdock, Mahasweta Gooptu, Vincent T. Ho, Roman M. Shapiro, Christopher J. Gibson, Amar H. Kelkar, Corey S. Cutler, Denbaa Bat-Erdene, Jeremy Ryan, Anna Bosch-Vilaseca, Anthony G. Letai, Jerome Ritz, Coleman Lindsley, Robert J. Soiffer, Joseph Antin
Journal: Blood (2024)
Final Analysis of a Phase 1 Study of Zanubrutinib Plus Lenalidomide in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Authors: Zheng Song, Ying Cheng, Haiyan Yang, Liling Zhang, Liqun Zou, Ye Guo, Junning Cao, Huiqiang Huang, Zhao Wang, Sha Huang, Yiqian Fang, Jiaoyan Lyu, Keshu Zhou, Huilai Zhang
Journal: Blood (2024)
Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks
Authors: Sophia Delicou, Fuad El Rassi, Biree Andemariam, Miguel R. Abboud, Julie Kanter, Marilyn J. Telen, Jessie Githanga, Adlette Inati, Ibrahim Idris, Sunil Navani, Eric Wu, Andrew Eisenberger
Journal: Blood (2024)
A Single-Center, Single-Arm, Phase I Clinical Trial of Anti-BCMA/GPRC5D Bispecific CAR T-Cells in Patients with Refractory and Relapsed Multiple Myeloma with Extramedullary Disease
Authors: Ling Qiu, Shihui Ren, Ying He, Dan Chen, Sihan Lai, Baitao Dou, Mengjiao Li, Rou Shu, Alex H. Chang, Yi Su, Hao Yao, Fangyi Fan
Journal: Blood (2024)
Safety and Efficacy of Tgrx-678, a Potent <i>BCR::ABL1</i> allosteric Inhibitor, in Patients with Tyrosine Kinase Inhibitor Resistant and/or Intolerant Chronic Myeloid Leukemia: Updated Results of Phase 1 Study Tgrx-678 -1001
Authors: Qian Jiang, Li Weiming, Yanli Zhang, Qiang Wang, Suning Chen, Bingcheng Liu, Zhuogang Liu, Jie Jin, Zhenfang Liu, Jianyu Weng, Xin Du, Xielan Zhao, Li Meng, Lie Lin, Wanlin Ye, Shujie Yan, Yihan Wang, Jingrong Cao
Journal: Blood (2024)
Genomic Complexity Correlates with the Degree of Marrow Independence of Malignant Plasma Cells in the Context of Extramedullary Disease
Authors: Kylee H Maclachlan, Juan-Jose Garces, Tala Shekarkhand, Sridevi Rajeeve, Hamza Hashmi, Hani Hassoun, Malin Hultcrantz, Neha Korde, Carlyn Rose Tan, Sham Mailankody, Anish Simhal, David J. Chung, Gunjan L. Shah, Michael Scordo, Sergio Giralt, Alexandra Maria Poos, Lukas John, Yanming Zhang, Robert Cimera, Maria E. Arcila, Juan E Arango Ossa, Umesh Bhanot, Mala Jain, Tala Merghoub, Heather J. Landau, Alexander M. Lesokhin, Saad Z. Usmani, Niels Weinhold, Francesco Maura, Urvi A. Shah
Journal: Blood (2024)
Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With <i>FLT3</i>-ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial
Authors: Mark J. Levis, Pau Montesinos, Hee-Je Kim, Radovan Vrhovac, Elzbieta Patkowska, Pavel Zak, Po-Nan Wang, Jorge E. Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Alexander E. Perl, Mitsuhiro Yazawa, Jaime E. Connolly Rohrbach, Venkat Thodima, Ken C. N. Chang, Li Liu, Karima Imadalou, Akash Nahar, Kristy Burns, Harry P. Erba
Journal: Blood (2024)
Donor Cell-Derived Hematologic Neoplasms: Role of Germline Predisposition and Clonal Hematopoiesis
Authors: Maria Gabarrós-Subirà, Helena Pomares, Elisa López-Fernández, Alberto Hernández-Sánchez, Lourdes Hermosín, Gonzalo Carreño, Ivan Martin Castillo, Juan Dominguez Garcia, Marta Santiago, Maria Jesús Pascual, Ana Batlle, Maria Julia Montoro, Blanca Ferrer Lores, Rosa Ayala, José Cervera, Lucia Lopez Corral, Francisca Maria Hernandez, Francesc Bosch, Montserrat Arnan, Carolina Martinez-Laperche, Andres Jerez
Journal: Blood (2024)
Ex Vivo Lentiviral Hematopoietic Stem Cell (HSC) Gene Therapy May Represent a Curative Therapy for the Life-Threatening Inborn Error of Immunity Severe Combined Immunodeficiency Due to Adenosine Deaminase (ADA) Deficiency (ADA-SCID)
Authors: Katelyn Masiuk, Jinhua Xu-Bayford, Augustine Fernandes, Konstantinos Vazouras, Danilo Pellin, Havinder Hara, Sohini Roy, Beatriz Campo Fernandez, Thao Thai Dang, Kimberly Gilmour, Elena Alvarez Mediavilla, Beatrice Curio-Penny, Gráinne O'Toole, Rima Ahmed, Jordyn Arnold, Elizabeth Garabedian, Harry L Malech, Kenneth Cornetta, Claire Booth, Donald B. Kohn
Journal: Blood (2024)
10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed <i>FLT3</i> Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years
Authors: Richard M Stone, Jun Yin, Sumithra J Mandrekar, Axel Benner, Maral Saadati, Ilene A. Galinsky, Ben L. Sanford, Rebecca Teske, Susan M. Geyer, Thomas Prior, Sergio Amadori, Frederick R. Appelbaum, Joseph Brandwein, Konstanze Döhner, Gerhard Ehninger, Arnold Ganser, Rebecca B. Klisovic, Jürgen Krauter, Guido Marcucci, Bruno Medeiros, Dietger W. Niederwieser, Miguel A. Sanz, Richard F. Schlenk, Hubert Serve, Jorge Sierra, Martin S. Tallman, Andrew H Wei, Theo J.M. de Witte, Christian Thiede, Hartmut Döhner, Richard A. Larson
Journal: Blood (2024)
Influence of AML Differentiation State in Risk Stratification of Frontline Therapy with Hypomethylating Agents + Venetoclax in AML
Authors: Curtis A Lachowiez, Joshua F Zeidner, Ashley M. Eckel, Daniel T Peters, Jacob Fang, Amenech Ashango, Andy Kaempf, Fangyan Dai, Christopher A. Eide, Stephen E. Kurtz, Theodore P Braun, Ronan T. Swords, Jennifer N. Saultz, Jeffrey W. Tyner, Daniel A Pollyea
Journal: Blood (2024)
A Phase 2 Study of Fedratinib in Patients with MDS/MPN and Chronic Neutrophilic Leukemia
Authors: Andrew T. Kuykendall, Tania Jain, Abhay Singh, Kristen M. Pettit, Quan Lovette, Joan McFadden Cain, Tracy Ann Cinalli, Mary Gallagher, David Sallman, Qianxing Mo, Ling Zhang, Onyee Chan, Alison R. Walker, Zhuoer Xie, Jeffrey E Lancet, Maria Balasis, Seongseok Yun, Eric Padron, Rami S. Komrokji
Journal: Blood (2024)
Dnmt3a Controls Hematopoietic Stem Cells Via DNA Methylation-Independent Regulation of Telomeres
Authors: Infencia Xavier Raj, Won Kyun Koh, Jessica Harrison, Christine RC Zhang, Barbara Soares, Aishwarya Krishnan, Hassan Bjeije, Tyler M Parsons, Wentao Han, Andrew L Young, Ting Wang, Luis Batista, Grant A Challen
Journal: Blood (2024)
An e-Health Pain Assessment Tool Incorporating Animations and Images Is Feasible and Useful for Patients in a Ghanaian Sickle Cell Disease Cohort
Authors: Modesty Obasohan, Catherine I. Segbefia, Charles R. Jonassaint, Eugenia Vicky Asare, Yvonne Dei Adomakoh, Cheryl Hillery, Olubusola Oluwole
Journal: Blood (2024)
Analysis of the Human CD5-Positive B-Cell Compartment As Cell-of-Origin of Chronic Lymphocytic Leukemia at Single-Cell Level
Authors: Cornelis A.M. van Bergen, Edwin Quinten, Julieta Haydeé Sepulveda Yanez, Ramin Monajemi, Roberta Menafra, Susan L. Kloet, Szymon M. Kiełbasa, Hendrik Veelken
Journal: Blood (2024)
Clinical Outcomes of Transformed Follicular Lymphoma with CAR T-Cell Therapy: A US Multicenter Real-World Analysis
Authors: Matthew J. Cortese, MD, MPH, Megan M Herr, Nisha Nair, Jason Romancik, Natalie Grover, Rahul S Bhansali, Colin Thomas, Tamara K Moyo, Vaishalee P Kenkre, Thomas Ollila, Brian Hess, Lindsey Fitzgerald, Geoffrey Shouse, Matthew Matasar, Kaitlin Annunzio, James A Davis, Christy Jesme, Ari Pelcovits, Megan Melody, Jonathan Moreira, Adam Yuh Lin, Shuo Ma, Jane N Winter, Alex Niu, Alexey V. Danilov, Nirav N. Shah, Deborah M. Stephens, Jonathon B. Cohen, Leo I. Gordon, Stefan K. Barta, Narendranath Epperla, Reem Karmali
Journal: Blood (2024)
Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort
Authors: Matthew Hamby, Brian Egleston, Zachary AK Frosch, Raphael E. Steiner, Ariela Noy, Veronica Carvajal, Seda S. Tolu, Gaston Jean-Louis, Jennifer E. Amengual, Romil Patel, Sairah Ahmed, Timothy Voorhees, Robert Baiocchi, Andres Ramirez-Gamero, Jorge J. Castillo, Emily Hamburger, Christopher Dittus, Imran A. Nizamuddin, Neha Mehta-Shah, Nyein Nyein Thaw Dar, Jose Sandoval-Sus, Alexandra E. Rojek, Peter A. Riedell, Vinod Solipuram, Paul G. Rubinstein, Anthony Ariotti, Gita Suneja, Alexander Vartanov, Charles Milrod, Adam J. Olszewski, Gordon Smilnak, Emily Ayers, Sahaj Desai, Joanna M. Rhodes, Gabriella Magarelli, Tatyana Feldman, Meredith Pellon, David M. Aboulafia, William Bae, Carlos Galvez, Vineel Bhatlapenumarthi, Mehdi Hamadani, Stefan K. Barta
Journal: Blood (2024)
Serial Clinical and Biomarker Monitoring during Treatment Can Stratify Patients with Low Risk Gvhd
Authors: Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vasova, Francis A. Ayuk, Hannah Choe, William J. Hogan, Zachariah Defilipp, Muna Qayed, Aaron Etra, Karamjeet S Sandhu, Sabrina Kraus, Timothy S. Olson, Elizabeth O. Hexner, Paibel Aguayo-Hiraldo, Ran Reshef, Evelyn Ullrich, Tal Schechter-Finkelstein, Carrie L. Kitko, Chantiya Chanswangphuwana, Pietro Merli, Yu Akahoshi, Janna Baez, Gilbert Eng, Rahnuma Beheshti, Steven Kowalyk, George Morales, Ioannis Evangelos Louloudis, Rachel Young, Ernst Holler, Ryotaro Nakamura, James L.M. Ferrara, John Levine
Journal: Blood (2024)
The Histone Acetyltransferase MOZ (KAT6A) Is a Molecular Dependency and Therapeutic Target in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
Authors: Nicole L Michmerhuizen, Emily Heikamp, Masayuki Umeda, Ilaria Iacobucci, Bright Arthur, Danika Di Giacomo, Ryan Hiltenbrand, Sandi Radko-Juettner, Pablo Portola, Aurelie Claquin, Bappaditya Chandra, David W Baggett, Hongling Huang, Peipei Zhou, Lingyun Long, Hao Shi, Yu Sun, Evangelia K Papachristou, Chandra Sekhar Reddy Chilamakuri, Francisca N. de L. Vitorino, Joanna M Gongora, Clive S D'Santos, Benjamin A Garcia, Richard W Kriwacki, Hongbo Chi, Alex Kentsis, Scott A Armstrong, Jeffery M Klco, Charles G. Mullighan
Journal: Blood (2024)
Safe and Effective Combination of Donor-Derived, Allogeneic CD19/CD22-CAR T Cells with Myeloablative Graft-Engineered Allo-HCT for High-Risk B-ALL
Authors: Lori Muffly, Snegha Ananth, Lindsay Danley, Caroline Wagner, Diana Kordek, Kimi DeNoble, Ayesha Fraser, Emily Egeler, Alfonso Molina, Zachary Ehlinger, Moksha Desai, Hossein Daghagh, Ramya Tunuguntla, Annie K. Brown, Raquel Ibañez, Anne Marijn Kramer, Zinaida Good, Sally Arai, Laura Johnston, Robert Lowsky, Andrew R. Rezvani, Judith Shizuru, Lekha Mikkilineni, Parveen Shiraz, Surbhi Sidana, Wen-Kai Weng, Vanessa E. Kennedy, Sushma Bharadwaj, Saurabh Dahiya, Matthew J. Frank, Everett H. Meyer, Robert S. Negrin, Steven A. Feldman, Crystal L. Mackall, Bita Sahaf, David B. Miklos, Melody Smith
Journal: Blood (2024)
Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease Aged 6 to &amp;lt;12 Years: 2-Year Data from the Phase 2 Solace-Kids Study
Authors: Matthew M. Heeney, David C Rees, Slimane Allali, Isaac Odame, Rodolfo D Cançado, Adlette Inati, Elena Cela, Deborah Keefe, Evgeniya Reshetnyak, Velusamy Shanmuganathan Muthusamy, Lidiya Bebrevska, Michele L Nassin, Julie Kanter
Journal: Blood (2024)
Safety and Efficacy of Bicistronic CD19/CD22 CAR T Cell Therapy in Childhood B Cell Acute Lymphoblastic Leukemia
Authors: Xinyu Wan, Wenjie Li, Jiaoyang Cai, Xiaomin Yang, Liu Yang, Jing Yang, Tianyi Wang, Yue Li, Zichao Zhou, Xiaoxi Lu, Zhiwei Xie, Jingbo Shao, Meng Su, Jing Zhang, Juan Qian, Kang An, Chengjuan Luo, Lixia Ding, Lili Song, Wenhua Shi, Jun Lu, Cheng Cheng, Yanjing Tang, Xuefeng Luo, Jingyu Li, Jian Hua, Benshang Li, Hua Zhang, Ching-Hon Pui
Journal: Blood (2024)
Phase 3 Study of Either Ivosidenib (IVO) Monotherapy or Azacitidine (AZA) Monotherapy in Patients with IDH1 Mutant Myelodysplastic Syndromes (MDS) Who Are Hypomethylating Agent (HMA) Naive (PyramIDH)
Authors: Marie Sebert, Uwe Platzbecker, David Valcarcel Ferreiras, Valeria Santini, Uma Borate, Stephanie M. Kapsalis, Lorene Simonot, Weishi Yuan, Prapti A. Patel, Guillermo Garcia-Manero
Journal: Blood (2024)
Ciltacabtagene Autoleucel (Cilta-cel) Vs Standard of Care (SoC) in Patients with Lenalidomide (Len)-Refractory Multiple Myeloma (MM) after 1-3 Lines of Therapy: Minimal Residual Disease (MRD) Negativity in the Phase 3 Cartitude-4 Trial
Authors: Rakesh Popat, Albert Oriol, Michele Cavo, Lionel Karlin, Irit Avivi Mazza, Wilfried Roeloffzen, Seok Jin Kim, Brea Lipe, Noffar Bar, Noemi Horvath, Andrew Spencer, Chang-Ki Min, Diana Chen, Quanlin Li, Katherine Li, Ana Slaughter, Carolina Lonardi, Nina Benachour, Arnab Ghosh, Martin Vogel, Nikoletta Lendvai, Tamar Lengil, Nitin Patel, Octavio Costa Filho, Erika Florendo, Yi Lin
Journal: Blood (2024)
Updated Results and Longer Follow-up from the AUGMENT-101 Phase 2 Study of Revumenib in All Patients with Relapsed or Refractory (R/R) <i>KMT2Ar</i> Acute Leukemia
Authors: Ibrahim Aldoss, Ghayas C. Issa, James S. Blachly, Michael J. Thirman, Gabriel N Mannis, Martha L. Arellano, John F. DiPersio, Elie Traer, C. Michel Zwaan, Neerav Shukla, Branko Cuglievan, Carolyn S. Grove, Matthew Greenwood, Christine M. McMahon, Alexander E. Perl, Richard M. Stone, Cristina Papayannidis, David S. Dickens, Maël Heiblig, Andrius Žučenka, Pau Montesinos, Ioannis Mantzaris, Tibor Kovacsovics, Paul J. Shami, Li Yu, Rebecca G. Bagley, Nicole McNeer, Eytan M. Stein
Journal: Blood (2024)
Temporal Trends in Relative Survival of Diffuse Large B-Cell Lymphoma in Sweden and Denmark in the Era of Targeted and Cellular Therapies: A Population-Based Binational Study
Authors: Sara Harrysson, Sandra Eloranta, Stefanie Antonilli, Mikkel Runason Simonsen, Kristina Sonnevi, Peter de Nully Brown, Bjorn E Wahlin, P-O Andersson, Judit Mészáros Joergensen, Mats Jerkeman, Christian Bjørn Poulsen, Gunilla Enblad, Tarec Christoffer El-Galaly, Karin Ekstroem Smedby
Journal: Blood (2024)
Final Analysis of the Safety and Efficacy of Venetoclax in Combination with Pola-R-CHP for Untreated High-Risk BCL-2-Positive B-Cell Lymphoma Including Double/Triple Hit Lymphoma
Authors: Catherine S. Diefenbach, Andrew D. Zelenetz, Charles Herbaux, Monica Tani, Roch Houot, Mariana Bastos-Oreiro, Hervé Tilly, Thomas Gastinne, Catherine Thieblemont, Wilfred Leung, Katerina Hatzi, Murali Kesavan, Simona Barlera, Michelle Boyer, Franck Morschhauser
Journal: Blood (2024)
Enhancing Personalized Prognostic Assessment of Myelodysplastic Syndromes through a Multimodal and Explainable Deep Data Fusion Approach (MAGAERA)
Authors: Elisabetta Sauta, Flavio Sartori, Luca Lanino, Gianluca Asti, Saverio D'Amico, Mattia Delleani, Elena Riva, Matteo Zampini, Elena Zazzetti, Marilena Bicchieri, Giulia Maggioni, Alessia Campagna, Gabriele Todisco, Cristina Astrid Tentori, Marta Ubezio, Antonio Russo, Alessandro Buizza, Francesca Ficara, Laura Crisafulli, Matteo Brindisi, Denise Ventura, Nicole Pinocchio, Daoud Rahal, Cesare Lancellotti, Arturo Bonometti, Luca Di Tommaso, Victor Savevski, Armando Santoro, Nicolas Riccardo Derus, Daniele Dall'Olio, Valeria Santini, Francesc Sole, Uwe Platzbecker, Pierre Fenaux, Maria Diez-Campelo, Rami S. Komrokji, Guillermo Garcia-Manero, Torsten Haferlach, Shahram Kordasti, Amer M. Zeidan, Gastone Castellani, Tiziana Sanavia, Piero Fariselli, Matteo Giovanni Della Porta
Journal: Blood (2024)
Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath
Authors: Kentaro Narita, Youichi Machida, Daisuke Ikeda, Rikako Tabata, Atsushi Uehara, Mitsuaki Oura, Fuminari Fujii, Hajime Sakuma, Masami Takeuchi, Kosei Matsue
Journal: Blood (2024)
Decoding the Pivotal Roles of BCL10 Activating Mutations in DLBCL Drug Resistance and Lymphomagenesis
Authors: Caroline A. Coughlin, Dhanvantri Chahar, Marianna Lekakis, Hsuan-Ting Huang, Abdessamad Youssfi Alaoui, Lingxiao Li, Evan Roberts, Natalia Campos Gallego, Claude-Henry Volmar, Ola Landgren, Shaun Brothers, Anthony Griswold, Catalina Amador, Daniel Bilbao, Francesco Maura, Jonathan H. Schatz
Journal: Blood (2024)
Blinatumomab and Ponatinib for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updated Results and Predictors of Relapse
Authors: Nicholas J. Short, Hagop Kantarjian, Nitin Jain, Koichi Takahashi, Ken Furudate, Jayastu Senapati, Fadi G. Haddad, Omer Karrar, Tapan M. Kadia, Kelly S. Chien, Koji Sasaki, Eitan Kugler, Rebecca Garris, Farhad Ravandi, Elias Jabbour
Journal: Blood (2024)
Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare
Authors: David T Yeung, Naranie Shanmuganathan, Agnes S. M. Yong, Jake Shortt, Lynette C.Y. Chee, Nicholas Vialla, Ilona Cunningham, David M Ross, Alwyn D'Souza, Matthew P.F. Wright, Rosemary Harrup, Cecily Forsyth, Robin Filshie, Steven W Lane, Peter J. Browett, Carolyn S. Grove, Mannu Walia, Susan Branford, John Reynolds, Andrew P Grigg, Timothy P Hughes
Journal: Blood (2024)
Comparison between Vulnerable Elders Survey-13 and Comprehensive Geriatric Assessment in Predicting Clinical Outcomes in Aggressive Lymphomas
Authors: Patrick Connor Johnson, Richard Newcomb, Jeremy S. Abramson, Ann S. LaCasce, Julia Rice, Daniel Yang, Bridget Coffey, Sruthi K. Venkatachalam, Netana H. Markovitz, Emilia Kaslow-Zieve, Oreofe O. Odejide, Areej El-Jawahri
Journal: Blood (2024)
Cytokine-Linked Remodeling of the Immune Microenvironment Is a Hallmark of Transformation in Follicular Lymphoma
Authors: Nicholas J. Haradhvala, Stephanie Yiu, Sam Sadigh, Laura Beckmann, Amber Pospistle, Stephanie Deng, Santiago Rivero, Yao Yu Yeo, Katie Maurer, Vignesh Shanmugam, McKayla Van Orden, Wesley S Lu, Shuqiang Li, Kenneth J. Livak, Huaying Qiu, Yuzhou Chang, Ankit Basak, Alex K Shalek, Mikaela M. McDonough, Robert A. Redd, Scott J. Rodig, Satyen Gohil, Donna S. Neuberg, Catherine J. Wu, Gad Getz, Sizun Jiang, Erin M. Parry
Journal: Blood (2024)
CD4 Cytotoxic T Cells Promote Antitumor Immunity in Multiple Myeloma
Authors: Sojeong Kim, Jeong-Eun Kwak, June-Young Koh, Hye Won Kook, Yu Ri Kim, Soo Jeong Kim, Jin Seok Kim, June-Won Cheong, Min Goo Lee, Hoyoung Lee, Eui-Cheol Shin, Kihyun Kim, Haerim Chung, Il-Kyu Choi, Jeong Seok Lee, Hyunsoo Cho
Journal: Blood (2024)